SIMVIAL Trademark

Trademark Overview


On Tuesday, July 16, 2019, a trademark application was filed for SIMVIAL with the United States Patent and Trademark Office. The USPTO has given the SIMVIAL trademark a serial number of 88516317. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 13, 2023. This trademark is owned by Pfizer Inc.. The SIMVIAL trademark is filed in the Pharmaceutical Products category with the following description:

Pre-filled and pre-assembled bottles and vials sold filled with pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, respiratory, urogenital, urological and viral diseases and disorders, blood disorders, liver disorders, cancer, pain and diabetes; Bottles and vials containing pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, respiratory, urogenital, urological and viral diseases and disorders, blood disorders, liver disorders, cancer, pain and diabetes
simvial

General Information


Serial Number88516317
Word MarkSIMVIAL
Filing DateTuesday, July 16, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 13, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 10, 2019

Trademark Statements


Goods and ServicesPre-filled and pre-assembled bottles and vials sold filled with pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, respiratory, urogenital, urological and viral diseases and disorders, blood disorders, liver disorders, cancer, pain and diabetes; Bottles and vials containing pharmaceuticals for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, psychiatric, respiratory, urogenital, urological and viral diseases and disorders, blood disorders, liver disorders, cancer, pain and diabetes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 22, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Monday, March 13, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 13, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 28, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 27, 2022SOU EXTENSION 5 GRANTED
Monday, May 23, 2022SOU EXTENSION 5 FILED
Friday, May 27, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, May 23, 2022TEAS EXTENSION RECEIVED
Thursday, January 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 4, 2022SOU EXTENSION 4 GRANTED
Tuesday, January 4, 2022SOU EXTENSION 4 FILED
Tuesday, January 4, 2022TEAS EXTENSION RECEIVED
Wednesday, June 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 14, 2021SOU EXTENSION 3 GRANTED
Monday, June 14, 2021SOU EXTENSION 3 FILED
Monday, June 14, 2021TEAS EXTENSION RECEIVED
Thursday, December 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 8, 2020SOU EXTENSION 2 GRANTED
Tuesday, December 8, 2020SOU EXTENSION 2 FILED
Tuesday, December 8, 2020TEAS EXTENSION RECEIVED
Saturday, June 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2020SOU EXTENSION 1 GRANTED
Thursday, June 25, 2020SOU EXTENSION 1 FILED
Thursday, June 25, 2020TEAS EXTENSION RECEIVED
Tuesday, February 4, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 10, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 10, 2019PUBLISHED FOR OPPOSITION
Wednesday, November 20, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 5, 2019ASSIGNED TO LIE
Tuesday, October 29, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, October 15, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 14, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 14, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 6, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, September 6, 2019NON-FINAL ACTION E-MAILED
Friday, September 6, 2019NON-FINAL ACTION WRITTEN
Wednesday, September 4, 2019ASSIGNED TO EXAMINER
Monday, July 22, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 19, 2019NEW APPLICATION ENTERED